These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 884664)
1. Improvement of phytohemagglutinin responsiveness of lymphocytes from cancer patients after washing in vitro. Mannick JA; Constantian M; Pardrige D; Saporoschetz I; Badger A Cancer Res; 1977 Sep; 37(9):3066-70. PubMed ID: 884664 [No Abstract] [Full Text] [Related]
2. Demonstration of nonspecific suppressor cells in the peripheral lymphocytes of cancer patients. Quan PC; Burtin P Cancer Res; 1978 Feb; 38(2):288-96. PubMed ID: 620401 [TBL] [Abstract][Full Text] [Related]
3. Association of anergy with an immunosuppressive peptide fraction in the serum of patients with cancer. Glasgow AH; Nimberg RB; Menzoian JO; Saporoschetz I; Cooperband SR; Schmid K; Mannick JA N Engl J Med; 1974 Dec; 291(24):1263-7. PubMed ID: 4610386 [No Abstract] [Full Text] [Related]
4. [A study on the lymphocyte culture with phytohaemagglutinin from patients with leukemia and cancer]. Kimoto M Zasshi Tokyo Ika Daigaku; 1969 Sep; 27(5):609-27. PubMed ID: 4915098 [No Abstract] [Full Text] [Related]
5. Inhibition of phytohemagglutinin-induced in vitro lymphocyte transformation by serum from patients with carcinoma. Sample WF; Gertner HR; Chretien PB J Natl Cancer Inst; 1971 Jun; 46(6):1291-7. PubMed ID: 5088049 [No Abstract] [Full Text] [Related]
6. The effect of phytohemagglutinin on lymphocytes from patients with renal insufficiency in in vitro cultures. Szewczyk Z; Melcer H Arch Immunol Ther Exp (Warsz); 1970; 18(4):460-72. PubMed ID: 5478578 [No Abstract] [Full Text] [Related]
7. In vitro behaviour of lymphocytes from cancer patients and normal individuals cultured with PHA. Datta U; Gupta BD; Mahajan MK; Aikat BK Indian J Cancer; 1977 Sep; 14(3):211-5. PubMed ID: 924501 [No Abstract] [Full Text] [Related]
8. Reaction of lymphocytes to phytohemagglutinin in vitro in hereditary microspherocytosis. Polkowska-Kulesza E; Pluźaska A; Judkiewicz L Pol Med Sci Hist Bull (1973); 1976; 15(2):221-4. PubMed ID: 959048 [TBL] [Abstract][Full Text] [Related]
9. Impaired responsiveness of lymphocytes and serum-inhibitory factors in patients with cancer. Suciu-Foca N; Buda J; McManus J; Thiem T; Reemtsma K Cancer Res; 1973 Oct; 33(10):2373-7. PubMed ID: 4270240 [No Abstract] [Full Text] [Related]
10. [Phytohemagglutinin stimulation of lymphocytes in patients with aplastic anemia]. Haas RJ; Kretschmer V; Fliedner TM Med Klin; 1970 Apr; 65(15):724-9. PubMed ID: 5522792 [No Abstract] [Full Text] [Related]
11. [The blood lymphocytes under the light- and electron microscope after stimulation with phytohemagglutinin. I. The effect of phytohemagglutinin on lymphocytes of healthy individuals]. Orfanos C; Pappas A; Scheurlen PG Z Gesamte Exp Med Einschl Exp Chir; 1969; 149(4):283-93. PubMed ID: 5772874 [No Abstract] [Full Text] [Related]
12. In vitro activation of lymphocytes from patients with malignant diseases. I. Kinetics and differences in magnitude of response. Benezra D; Hochman A Isr J Med Sci; 1971 Apr; 7(4):553-60. PubMed ID: 5281061 [No Abstract] [Full Text] [Related]
13. [Blastic transformation by means of phytohemagglutinin of human lymphocytes cultured in vitro in the presence of homologous plasma]. Rugarli C; Tossi B; Scorza R; Besana C; Malacco E Haematol Lat; 1968; 11(4):367-73. PubMed ID: 5736507 [No Abstract] [Full Text] [Related]
14. Surface markers on human lymphocytes: studies of normal subjects and of patients with primary immunodeficiencies. Aiuti F; Lacava V; Garofalo JA; D'Amelio R; D'Asero C Clin Exp Immunol; 1973 Sep; 15(1):43-52. PubMed ID: 4587827 [TBL] [Abstract][Full Text] [Related]
15. Clinical immunologic responsiveness in malignant disease. II. In vitro lymphocyte response to phytohemagglutinin and the effect of cytotoxic drugs. al-Sarraf M; Sardesai S; Vaitkevicius VK Oncology; 1972; 26(4):357-68. PubMed ID: 5055855 [No Abstract] [Full Text] [Related]
16. [Studies on immunological responsiveness of cancer patients. I. Standardization of phytohemagglutinin-stimulated lymphocyte transformation]. Kumashiro R Fukuoka Igaku Zasshi; 1976 Sep; 67(9):331-8. PubMed ID: 1033894 [No Abstract] [Full Text] [Related]
17. Isolation of an immunosuppressive peptide fraction from the serum of cancer patients. Nimberg RB; Glasgow AH; Menzoian JO; Constantian MB; Cooperband SR; Mannick JA; Schmid K Cancer Res; 1975 Jun; 35(6):1489-94. PubMed ID: 1131820 [TBL] [Abstract][Full Text] [Related]
18. [Studies on immunological responsiveness of cancer patients. II. Phytohemagglutinin-stimulated lymphocyte transformation in patients with gastric or esophageal cancer]. Kumashiro R Fukuoka Igaku Zasshi; 1976 Sep; 67(9):339-49. PubMed ID: 1033895 [No Abstract] [Full Text] [Related]
19. Evaluation of host immunity in human neoplasia. 1. Discussion. Br J Cancer Suppl; 1973 Aug; 1():108-18. PubMed ID: 4804275 [No Abstract] [Full Text] [Related]
20. [The effect of phytohemagglutinin on lymphocytes in Hodgkin's disease]. Eggerth G; Kühböck J; Pokorny D Wien Z Inn Med; 1969; 50(7):314-9. PubMed ID: 5380683 [No Abstract] [Full Text] [Related] [Next] [New Search]